Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study.
Pérez-Fernández L, Sastre J, Zafón C, Oleaga A, Castelblanco E, Capel I, Galofré JC, Guadalix-Iglesias S, De la Vieja A, Riesco-Eizaguirre G. Pérez-Fernández L, et al. Among authors: castelblanco e. Front Endocrinol (Lausanne). 2023 Jan 13;13:1071775. doi: 10.3389/fendo.2022.1071775. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36714606 Free PMC article.
DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Rodríguez-Rodero S, Fernández AF, Fernández-Morera JL, Castro-Santos P, Bayon GF, Ferrero C, Urdinguio RG, Gonzalez-Marquez R, Suarez C, Fernández-Vega I, Fresno Forcelledo MF, Martínez-Camblor P, Mancikova V, Castelblanco E, Perez M, Marrón PI, Mendiola M, Hardisson D, Santisteban P, Riesco-Eizaguirre G, Matías-Guiu X, Carnero A, Robledo M, Delgado-Álvarez E, Menéndez-Torre E, Fraga MF. Rodríguez-Rodero S, et al. Among authors: castelblanco e. J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21. doi: 10.1210/jc.2012-3566. Epub 2013 May 10. J Clin Endocrinol Metab. 2013. PMID: 23666970
DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V, Buj R, Castelblanco E, Inglada-Pérez L, Diez A, de Cubas AA, Curras-Freixes M, Maravall FX, Mauricio D, Matias-Guiu X, Puig-Domingo M, Capel I, Bella MR, Lerma E, Castella E, Reverter JL, Peinado MÁ, Jorda M, Robledo M. Mancikova V, et al. Among authors: castelblanco e. Int J Cancer. 2014 Aug 1;135(3):598-610. doi: 10.1002/ijc.28703. Epub 2014 Jan 13. Int J Cancer. 2014. PMID: 24382797 Free article.
MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.
Mancikova V, Castelblanco E, Pineiro-Yanez E, Perales-Paton J, de Cubas AA, Inglada-Perez L, Matias-Guiu X, Capel I, Bella M, Lerma E, Riesco-Eizaguirre G, Santisteban P, Maravall F, Mauricio D, Al-Shahrour F, Robledo M. Mancikova V, et al. Among authors: castelblanco e. Mod Pathol. 2015 Jun;28(6):748-57. doi: 10.1038/modpathol.2015.44. Epub 2015 Feb 27. Mod Pathol. 2015. PMID: 25720323 Free article.
Genetics: Is LADA just late onset type 1 diabetes?
Hernández M, Nóvoa-Medina Y, Faner R, Palou E, Esquerda A, Castelblanco E, Wägner AM, Mauricio D. Hernández M, et al. Among authors: castelblanco e. Front Endocrinol (Lausanne). 2022 Aug 10;13:916698. doi: 10.3389/fendo.2022.916698. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034444 Free PMC article.
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results.
Castelblanco E, Gallel P, Ros S, Gatius S, Valls J, De-Cubas AA, Maliszewska A, Yebra-Pimentel MT, Menarguez J, Gamallo C, Opocher G, Robledo M, Matias-Guiu X. Castelblanco E, et al. Hum Pathol. 2012 Jul;43(7):1103-12. doi: 10.1016/j.humpath.2011.08.022. Epub 2011 Dec 29. Hum Pathol. 2012. PMID: 22209341
Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors.
Mancikova V, Montero-Conde C, Perales-Paton J, Fernandez A, Santacana M, Jodkowska K, Inglada-Pérez L, Castelblanco E, Borrego S, Encinas M, Matias-Guiu X, Fraga M, Robledo M. Mancikova V, et al. Among authors: castelblanco e. Clin Cancer Res. 2017 Mar 1;23(5):1334-1345. doi: 10.1158/1078-0432.CCR-16-0947. Epub 2016 Sep 12. Clin Cancer Res. 2017. PMID: 27620278 Free article.
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
Julián MT, Pera G, Soldevila B, Caballería L, Julve J, Puig-Jové C, Morillas R, Torán P, Expósito C, Puig-Domingo M, Castelblanco E, Franch-Nadal J, Cusi K, Mauricio D, Alonso N. Julián MT, et al. Among authors: castelblanco e. Eur J Endocrinol. 2021 Apr;184(4):587-596. doi: 10.1530/EJE-20-1240. Eur J Endocrinol. 2021. PMID: 33606661
66 results